To control Covid-19 in a more effective way, leading face mask manufacturers have adopted technologies like Virus Protection Technology (VPT) approved by regulatory authorities globally to ensure maximum breathability while ensuring protection through anti-viral and anti-bacterial coating.
Alarmed with the new strain of virus post Covid-19 outbreak, Union health ministry is also in the process of evolving harmonized standard for community face coverings and is encouraging manufacturers to develop uniquely designed breath-easy mask equipped with superior technologies like VPT to ensure maximum breathability while keeping the consumer and patient protected.
The proprietary VPT technology which has been developed by leading mask manufacturer Guardwiser in India is a non-alcoholic, non-heavy metal based – food grade product. It has naturally derived ingredients sourced from coconut oil. VPT technology is a single solution for multiple problems such as bacteria, viruses, fungi and mold. The mask is stabilized in food grade aqueous solution whereas other mask coating is metal based. The technology is non-leaching, locking and bonding technology. It kills microbes by a mechanical process and not by a chemical method.
ADVANTAGE of VPT technology
- Proven to have 99.9% anti-bacterial & anti-odour efficacy even after 100 washes
- Anti-viral efficacy even after 50 washes
- N99 filter between the two fabric layers filters more than 99% of airborne particulate matter greater than 2.5 microns
- The non-leaching, locking and bonding technology and sticks to garment for up to 100 washes
- Uniqueness lies in green technology as it decomposes like oxygen, nitrogen and sand
- Does not penetrate the skin nor accumulates in the environment and does not contain carcinogenic compounds
Whereas other mask coating is metal based and erodes after a few washes. Chemical methods used in such mask to kill microbes pollute riverbeds, soil and environment. It also bio accumulates in body and environment and contains carcinogenic compounds.
N99 Breath easy mask is equipped with the revolutionary breakthrough VPT. Its ingredients are approved by USEPA, European BPR, New Zealand primary industry for the use of food contact surfaces and Therapeutic Goods Administration (TGA), Ministry of Health, Australia for the claim against corona virus.
Reference: Pharmabiz.com
Donald Trump’s tariffs of 50% have come into force on most US imports from India. India’s giant generic pharmaceuticals sector and its electronics and petroleum products are exempt from the tariffs. Aluminium, steel and copper remain at 25%, but job-heavy sectors such as textiles, jewellery, seafood and leather are squarely in the line of fire.
The European Chemicals Agency (ECHA) has published the updated proposal to restrict per- and polyfluoroalkyl substances (PFAS) under the EU’s chemicals regulation, REACH. The update has been prepared by the authorities from Denmark, Germany, the Netherlands, Norway and Sweden, who submitted the initial proposal in January 2023.
Most chemicals exported from the 27 member countries of the European Union into the US will be subject to a 15% tariff on top of their selling prices under an agreement signed on July 27 between the US and the European Commission.
We’re thrilled to announce a new strategic alliance between ExSyn, Exim-Indis and simABs, a leading EU-based biologics manufacturer known for its patented continuous flow technology in antibody production.
The global trade landscape is undergoing significant changes following the announcement of new reciprocal tariffs by the United States government. Recent developments indicate significant shifts in global trade dynamics, with key policy adjustments, ongoing negotiations, and evolving logistics patterns. Below is a summary of the latest developments.
In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.
The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.
In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?
High duties on imports from Canada, Mexico and China raise problems for international supply chains.